183 related articles for article (PubMed ID: 15302096)
1. Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines.
Kanno S; Higurashi A; Watanabe Y; Shouji A; Asou K; Ishikawa M
Toxicol Lett; 2004 Sep; 152(2):149-58. PubMed ID: 15302096
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
3. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
Kanno S; Hiura T; Ohtake T; Koiwai K; Suzuki H; Ujibe M; Ishikawa M
Clin Chim Acta; 2007 Feb; 377(1-2):144-9. PubMed ID: 17097625
[TBL] [Abstract][Full Text] [Related]
4. An oxidative stress-mediated death pathway in irradiated human leukemia cells mapped using multilaser flow cytometry.
Sheng-Tanner X; Bump EA; Hedley DW
Radiat Res; 1998 Dec; 150(6):636-47. PubMed ID: 9840183
[TBL] [Abstract][Full Text] [Related]
5. Enforced expression of the tumor suppressor p53 renders human leukemia cells (U937) more sensitive to 1-[beta-D-arabinofuranosyl]cytosine (ara-C)-induced apoptosis.
Decker RH; Levin J; Kramer LB; Dai Y; Grant S
Biochem Pharmacol; 2003 Jun; 65(12):1997-2008. PubMed ID: 12787880
[TBL] [Abstract][Full Text] [Related]
6. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
Qin T; Youssef EM; Jelinek J; Chen R; Yang AS; Garcia-Manero G; Issa JP
Clin Cancer Res; 2007 Jul; 13(14):4225-32. PubMed ID: 17634552
[TBL] [Abstract][Full Text] [Related]
7. Effects of naringin on cytosine arabinoside (Ara-C)-induced cytotoxicity and apoptosis in P388 cells.
Kanno S; Shouji A; Hirata R; Asou K; Ishikawa M
Life Sci; 2004 Jun; 75(3):353-65. PubMed ID: 15135655
[TBL] [Abstract][Full Text] [Related]
8. Anti-Fas IgM monoclonal antibody enhances apoptosis induced by low-dose cytosine arabinoside.
Nakamura S; Takeshima M; Nakamura Y; Ohtake S; Matsuda T
Anticancer Res; 1999; 19(1A):197-204. PubMed ID: 10226543
[TBL] [Abstract][Full Text] [Related]
9. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
[TBL] [Abstract][Full Text] [Related]
10. Involvement of p53 in 1-beta-D-arabinofuranosylcytosine-induced trophoblastic cell apoptosis and impaired proliferation in rat placenta.
Yamauchi H; Katayama K; Ueno M; Uetsuka K; Nakayama H; Doi K
Biol Reprod; 2004 Jun; 70(6):1762-7. PubMed ID: 14766721
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
[TBL] [Abstract][Full Text] [Related]
12. Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities.
Majlessipour F; Kwock R; Martin-Aragon S; Weinberg KI; Avramis VI
Anticancer Res; 2001; 21(1A):11-22. PubMed ID: 11299723
[TBL] [Abstract][Full Text] [Related]
13. A synergistic increase of apoptosis utilizing Fas antigen expression induced by low doses of anticancer drug.
Akiyama H; Ino T; Tokunaga E; Katsuda I; Ezaki K
Rinsho Byori; 2003 Aug; 51(8):733-9. PubMed ID: 13677932
[TBL] [Abstract][Full Text] [Related]
14. Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.
Fu CH; Martin-Aragon S; Weinberg KI; Ardi VC; Danenberg PV; Avramis VI
Cancer Chemother Pharmacol; 2001 Aug; 48(2):123-33. PubMed ID: 11561778
[TBL] [Abstract][Full Text] [Related]
15. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
Lei XY; Zhang H; He DM
Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735
[TBL] [Abstract][Full Text] [Related]
16. [Ara-c induced apoptosis in human myeloid leukemia cell line HL-60].
Zhou J; Chen Y; Li C
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):107-10. PubMed ID: 10743072
[TBL] [Abstract][Full Text] [Related]
17. All- trans-retinoic acid increases cytotoxicity of 1-beta-D-arabinofuranosylcytosine in NB4 cells.
Flanagan SA; Meckling KA
Cancer Chemother Pharmacol; 2003 May; 51(5):363-75. PubMed ID: 12736759
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses.
Negoro E; Yamauchi T; Urasaki Y; Nishi R; Hori H; Ueda T
Int J Oncol; 2011 Apr; 38(4):911-9. PubMed ID: 21290089
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H
Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]